Patents by Inventor Patricia Flanagan

Patricia Flanagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Percutaneous repair of mitral prolapse
    Patent number: 11918470
    Abstract: A mitral valve leaflet repair system may include a delivery catheter having at least one lumen extending proximally from a distal end of the delivery catheter, a plurality of anchor elements disposed within the at least one lumen, each of the plurality of anchor elements being configured to extend through one layer of mitral valve leaflet tissue, and a securing element configured to secure at least two of the plurality of anchor elements together on one side of the mitral valve leaflet tissue. The at least one lumen may include a suction lumen configured to grasp a mitral valve leaflet prior to extending the plurality of anchor elements through one layer of mitral valve leaflet tissue.
    Type: Grant
    Filed: October 11, 2021
    Date of Patent: March 5, 2024
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Omar Jarral, Patricia McAfee, Aiden Flanagan, Tim O'Connor, Jan Weber
  • Bioerodible device for administering active ingredients
    Patent number: 5891458
    Abstract: The invention relates to a muco-adherent, soluble device for administering active ingredients, a method of using said device, and an improved method of manufacturing said device using a continuous, enclosed mixing device capable of operating under pressure. The devices of the invention, which comprise a lyophilized foam and an active ingredient, have a dissolution time of at least about 8 hours, and preferably at least about 24 hours, and can provide for the sustained and/or controlled release of an active ingredient for up to about 24 hours.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: April 6, 1999
    Inventors: Peter Britton, Patricia Flanagan, William P. Hart, Deborah Linkin
  • Bioerodible contraceptive suppository
    Patent number: 5863553
    Abstract: The invention relates to an intravaginally-dissolvable contraceptive suppository, a method of using said suppository, and an improved method of manufacturing said birth control device. The suppositories of the invention, which comprise a lyophilized foam and a contraceptive, have a dissolution time of at least about 2 hours, and up to about 24 hours, and provide superior protection against pregnancy.
    Type: Grant
    Filed: March 7, 1997
    Date of Patent: January 26, 1999
    Assignee: McNeil-PPC, Inc.
    Inventors: Peter Britton, Patricia Flanagan, William P. Hart, Deborah Linkin
  • Method for manufacturing buccal delivery device
    Patent number: 5650192
    Abstract: The invention relates to a muco-adherent, soluble device for administering active ingredients, a method of using said device, and an improved method of manufacturing said device using a continuous, enclosed mixing device capable of operating under pressure. The devices of the invention, which comprise a lyophilized foam and an active ingredient, have a dissolution time of at least about 8 hours, and preferably at least about 24 hours, and can provide for the sustained and/or controlled release of an active ingredient for up to about 24 hours.
    Type: Grant
    Filed: July 10, 1995
    Date of Patent: July 22, 1997
    Inventors: Peter Britton, Patricia Flanagan, William P. Hart, Deborah Linkin
  • Bioerodible device for administering active ingredients
    Patent number: 5458884
    Abstract: The invention relates to a muco-adherent, soluble device for administering active ingredients, a method of using said device, and an improved method of manufacturing said device using a continuous, enclosed mixing device capable of operating under pressure. The devices of the invention, which comprise a lyophilized foam and an active ingredient, have a dissolution time of at least about 8 hours, and preferably at least about 24 hours, and can provide for the sustained and/or controlled release of an active ingredient for up to about 24 hours.
    Type: Grant
    Filed: August 16, 1993
    Date of Patent: October 17, 1995
    Inventors: Peter Britton, Patricia Flanagan, William P. Hart, Deborah Linkin
  • Bioerodible contraceptive suppository
    Patent number: 5354558
    Abstract: The invention relates to an intravaginally-dissolvable contraceptive suppository, a method of using said suppository, and an improved method of manufacturing said birth control device. The suppositories of the invention, which comprise a lyophilized foam and a contraceptive, have a dissolution time of at least about 2 hours, and up to about 24 hours, and provide superior protection against pregnancy.
    Type: Grant
    Filed: September 10, 1992
    Date of Patent: October 11, 1994
    Assignee: McNeil-PCC, Inc.
    Inventors: Peter Britton, Patricia Flanagan, William P. Hart, Deborah Linkin